Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

The highly lethal brain cancer glioblastoma (GBM) poses a daunting challenge because the blood-brain barrier renders potentially druggable amplified or mutated oncoproteins relatively inaccessible. Here, we identify sphingomyelin phosphodiesterase 1 (SMPD1), an enzyme that regulates the conversion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Junfeng, Khan, Atif, Tang, Jun, Armando, Aaron M., Wu, Sihan, Zhang, Wei, Gimple, Ryan C., Reed, Alex, Jing, Hui, Koga, Tomoyuki, Wong, Ivy Tsz-Lo, Gu, Yuchao, Miki, Shunichiro, Yang, Huijun, Prager, Briana, Curtis, Ellis J., Wainwright, Derek A., Furnari, Frank B., Rich, Jeremy N., Cloughesy, Timothy F., Kornblum, Harley I., Quehenberger, Oswald, Rzhetsky, Andrey, Cravatt, Benjamin F., Mischel, Paul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856626/
https://www.ncbi.nlm.nih.gov/pubmed/34731610
http://dx.doi.org/10.1016/j.celrep.2021.109957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856626/
https://www.ncbi.nlm.nih.gov/pubmed/34731610
http://dx.doi.org/10.1016/j.celrep.2021.109957

Ejemplares similares